Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 510

Results For "STI"

6895 News Found

Eppendorf India inaugurates pipette laboratory and service hub in Chennai
Biotech | June 11, 2022

Eppendorf India inaugurates pipette laboratory and service hub in Chennai

SPLASH also houses the tools’ calibration for epMotion, Eppendorf automated liquid handling workstations.


TaCa Healthcare expands its operations to Telangana and Andhra Pradesh
Healthcare | June 11, 2022

TaCa Healthcare expands its operations to Telangana and Andhra Pradesh

Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states


AIkido Pharma appoints Soo Yu as Director
People | June 11, 2022

AIkido Pharma appoints Soo Yu as Director

New Director supports NASDAQ rule on diversity


Illumina appoints Joydeep Goswami as Interim CFO
People | June 11, 2022

Illumina appoints Joydeep Goswami as Interim CFO

Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.


Nippon Express launches ultra-low temperature-controlled service for pharma industry
Supply Chain | June 11, 2022

Nippon Express launches ultra-low temperature-controlled service for pharma industry

Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C


Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus
Clinical Trials | June 10, 2022

Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus

Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.


Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies
News | June 10, 2022

Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies

During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.


Sanofi Dupixent gets USFDA nod for atopic dermatitis
Drug Approval | June 10, 2022

Sanofi Dupixent gets USFDA nod for atopic dermatitis

Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood


India's bio-economy has grown 8 times in the last 8 years: PM Modi
Biotech | June 10, 2022

India's bio-economy has grown 8 times in the last 8 years: PM Modi

We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”


Sumitomo Pharma Oncology receives orphan drug designation for the treatment of myelofibrosis
Drug Approval | June 09, 2022

Sumitomo Pharma Oncology receives orphan drug designation for the treatment of myelofibrosis

TP-3654 is currently being evaluated in a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with intermediate or high-risk primary or secondary myelofibrosis.